Company intelligence / Profile preview

Innovotech

Edmonton, Alberta, Canada

Ownership: Private
Employees: ~16
Development stage: Other

Overview

Innovotech generates revenues from multiple platforms including MBEC Assay® kits used globally by researchers and contract research services for over 100 companies. The company is profitable and continues to develop its InnovoSIL™ antimicrobial silver compound family, which has demonstrated efficacy against medically important pathogens.

Therapeutic areas: OtherDermatologyInfectious Diseases
Modalities: Assay kitsScreening devicesContract research servicesSmall molecule
Industry: Consumable Medical Devices

Partnerships

Medical device companies for InnovoSIL™-1 developmentCanBiocin Inc.Global pharmaceutical and medical device companies as contract research clients

Beyond the preview

Go deeper on Innovotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovotech.

Explore the full profile